Skip to content

AVP

VC fundVerified by OSH — Confirmed by at least two independent sources or a primary document (filing, official announcement).

AVP is a vc fund. It joined 2 rounds tracked by OSH in the last 90 days.

What they look for

Based on deals tracked by OSH, AVP participates in late-stage and growth rounds with a focus on high-scale enterprise and technology companies, frequently serving as a lead investor.

Stages
Growth
Leads rounds
Yes

Derived from deals tracked by OSH, not published by the investor.

Activity

2
Deals, 90 days
2
Deals, 12 months
2
Led, 12 months
$63.1M
Median disclosed round

Frequent co-investors:HillspireYaday HealthBlast ClubOmnes CapitalDebiopharm Innovation Fund

Computed from OSH Rounds. A deal is a round the investor led or joined.

Portfolio from OSH Rounds

  • Oct 6 · Series C

    Parallel Systems$100M

    Led by AVP · with Hillspire, +6

    1 source

  • Oct 5 · Series B

    WhiteLab Genomics€23.2M

    Led by AVP · with Yaday Health, +3

    1 source

Questions and answers

What stages does AVP invest in?

AVP invests at Growth (derived by OSH from its deals).

How active is AVP?

In OSH Rounds, AVP joined 2 rounds in the last 90 days and 2 in the last 12 months, leading 2.

Does AVP lead rounds?

Yes, AVP leads rounds.

Something wrong? Suggest a correction.

Sources

  1. 1.Paris-based WhiteLab Genomics raises €23.2 million to accelerate AI-driven genomic medicine development — EU-Startups, Oct 6, 2026
  2. 2.SpaceX alumni nab $100M to rethink shipping with autonomous freight trains — TechCrunch Startups, Oct 7, 2026
  3. 3.OSH Investors — OSH Investors

Verified by OSH — Confirmed by at least two independent sources or a primary document (filing, official announcement).Last verified Oct 15, 2026